Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Fenofibrate recalled?

Yes — there is an active recall. 2 ongoing FDA recalls mention Fenofibrate (11 total). Check the affected lots below.

Most common reason: Labeling / mix-up (6 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Fenofibrate. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Fenofibrate recalls in 2026

1 initiated in 2026, 11 in total — newest first
Class II · Moderate risk

Fenofibrate Capsules

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. D-0407-2021
Class III · Low risk

Fenofibrate Tablets

Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.

Terminated Particulate / foreign matter Hetero Labs, Ltd. - Unit III NDC 31722-596-90 D-1211-2018
Class III · Low risk

Fenofibrate Capsules

Labeling: Incorrect or Missing Lot and/or Exp Date

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-835-32 D-0823-2016
Class III · Low risk

Fenofibrate Capsules

Labeling: Incorrect or Missing Lot and/or Exp Date

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-835-32 D-0822-2016
Class III · Low risk

Fenofibrate Capsules

Labeling: Incorrect or Missing Lot and/or Exp. Date

Terminated Labeling / mix-up Impax Laboratories, Inc. NDC 0115-0533-02 D-0821-2016
Class III · Low risk

Fenofibrate Capsules

Labeling: Incorrect or Missing Lot and/or Exp. Date

Terminated Labeling / mix-up Impax Laboratories, Inc. NDC 0115-0522-02 D-0820-2016
Class II · Moderate risk

Fenoglide (fenofibrate)

Failed Dissolution Specifications: Failed 24 month dissolution testing.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC D-0163-2016
Class II · Moderate risk

Fenofibrate

Labeling: Label Mixup: FENOFIBRATE, Tablet, 54 mg may have potentially been mislabeled as one of the following drugs: LUBIPROSTONE, Capsule, 24 MCG, NDC 64764024060, Pedigree: AD21790_46, EXP: 5/1/2014; aMILoride HCl, Tablet, 5 mg, NDC 64980015101, Pedigree: AD60272_55, EXP: 5/22/2014; PROPRANOLOL HCL, Tablet, 10 mg, NDC 23155011001, Pedigree: W002732, EXP: 6/6/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-909-2014
Class II · Moderate risk

Fenofibrate

Labeling: Label Mixup: FENOFIBRATE, Tablet, 54 mg may have potentially been mislabeled as the following drug: FAMCICLOVIR, Tablet, 500 mg, NDC 00093811956, Pedigree: AD49448_4, EXP: 5/17/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-860-2014